Tumor antigen specific iTreg accumulate in the tumor microenvironment and suppress therapeutic vaccination

le Schreiber, Taylor H., Wolf, Dietlinde, Bodero, Maria, Podack, Eckhard
Foilsithe 2012

The promise of CD4(+)FoxP3(+) regulatory T-cell manipulation in vivo: applications for allogeneic hematopoietic stem cell transplantation

le Copsel, Sabrina, Wolf, Dietlinde, Komanduri, Krishna V., Levy, Robert B.
Foilsithe in Haematologica (2019)

T Cell Costimulation by TNFRSF4 and TNFRSF25 in the Context of Vaccination

le Schreiber, Taylor H., Wolf, Dietlinde, Bodero, Maria, Gonzalez, Louis, Podack, Eckhard R.
Foilsithe 2012

Induction of Fas Ligand Expression by HIV Involves the Interaction of Nef with the T Cell Receptor ζ Chain

le Xu, Xiao-Ning, Laffert, Bernd, Screaton, Gavin R., Kraft, Michael, Wolf, Dietlinde, Kolanus, Waldemar, Mongkolsapay, Juthathip, McMichael, Andrew J., Baur, Andreas S.
Foilsithe 1999

Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation

le Schreiber, Taylor H., Wolf, Dietlinde, Tsai, Matthew S., Chirinos, Jackie, Deyev, Vadim V., Gonzalez, Louis, Malek, Thomas R., Levy, Robert B., Podack, Eckhard R.
Foilsithe 2010

Superior immune reconstitution using Treg-expanded donor cells versus PTCy treatment in preclinical HSCT models

le Wolf, Dietlinde, Bader, Cameron S., Barreras, Henry, Copsel, Sabrina, Pfeiffer, Brent J., Lightbourn, Casey O., Altman, Norman H., Komanduri, Krishna V., Levy, Robert B.
Foilsithe in JCI Insight (2018)

Very Low Numbers of CD4(+)FoxP3(+) Tregs Expanded in Donors via TL1A-Ig and Low Dose IL-2 Exhibit a Distinct Activation / Functional Profile and Suppress GVHD in a Pre-clinical Mod...

le Copsel, Sabrina, Wolf, Dietlinde, Kale, Brandon, Barreras, Henry, Lightbourn, Casey O., Bader, Cameron S., Alperstein, W., Altman, Norman H., Komanduri, Krishna V., Levy, Robert B.
Foilsithe in Biol Blood Marrow Transplant (2018)

Marked in vivo Donor Treg Expansion via IL-2 and TL1A-Ig stimulation ameliorates GVHD but preserves GVL in recipients post-HSCT

le Wolf, Dietlinde, Barreras, Henry, Bader, Cameron S., Copsel, Sabrina, Lightbourn, Casey O., Pfeiffer, Brent J., Altman, Norman H., Podack, Eckhard R., Komanduri, Krishna V., Levy, Robert B.
Foilsithe in Biol Blood Marrow Transplant (2017)

Use of Post-transplant Cyclophosphamide Treatment to Build a Tolerance Platform to Prevent Liquid and Solid Organ Allograft Rejection

le Lightbourn, Casey O., Wolf, Dietlinde, Copsel, Sabrina N., Wang, Ying, Pfeiffer, Brent J., Barreras, Henry, Bader, Cameron S., Komanduri, Krishna V., Perez, Victor L., Levy, Robert B.
Foilsithe in Front Immunol (2021)

STING differentially regulates experimental GVHD mediated by CD8 versus CD4 T cell subsets

le Bader, Cameron S, Barreras, Henry, Lightbourn, Casey O, Copsel, Sabrina N, Wolf, Dietlinde, Meng, Jingjing, Ahn, Jeonghyun, Komanduri, Krishna V, Blazar, Bruce R, Jin, Lei, Barber, Glen N, Roy, Sabita, Levy, Robert B
Foilsithe in Sci Transl Med (2020)

BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT

le Copsel, Sabrina N., Lightbourn, Casey O., Barreras, Henry, Lohse, Ines, Wolf, Dietlinde, Bader, Cameron S., Manov, John, Kale, Brandon J., Shah, Devangi, Brothers, Shaun P., Perez, Victor L., Komanduri, Krishna V., Wahlestedt, Claes, Levy, Robert B.
Foilsithe in Front Immunol (2019)